Royal Bank of Canada »

Conduit Pharmaceuticals shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Conduit Pharmaceuticals (CDT) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Conduit Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Conduit Pharmaceuticals held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Conduit Pharmaceuticals by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2024-09-30 $0 2.7k 0.00
2024-06-30 $2.0k 2.2k 0.92

More positions owned by Royal Bank of Canada

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Toronto Dominion Bk Ont Com New (TD)
Rbc Cad (RY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
Bk Nova Cad (BNS)
Ishares Tr Russell 2000 Etf (IWM)
Bank Of Montreal Cadcom (BMO)
JPMorgan Chase & Co. (JPM)
Enbridge (ENB)
Cibc Cad (CM)

View all positions for Royal Bank of Canada

Top funds holding Conduit Pharmaceuticals

Barclays
BlackRock
BlackRock
Geode Capital Management
Vanguard Group
Citadel Advisors
Northern Trust
New York State Common Retirement Fund
State Street Corporation
Morgan Stanley
Charles Schwab Investment Management
Bridgeway Capital Management
JustInvest
SG Americas Securities
AQR Capital Management

View all funds holding Conduit Pharmaceuticals